Actelion may interest large pharma

Swiss-based biopharmaceutical firm Actelion could attract the interest of large pharmaceuticals companies, according to an analyst. Bank Vontobel’s pharmaceutical analyst Andrew Weiss says that Actelion retains its long term value…